Enovix is trading 5.5% down at $2.74, with no clear company-specific announcement explaining the October 1 move.
- Previously issued shareholder warrants are scheduled to expire at 5 p.m. on October 1, but available sources do not establish that expiration as the cause of the decline.
- The Nasdaq is up 0.57% and the S&P 500 is up 0.25%; no reliable evidence ties the move to broad-market weakness or a sector catalyst.